BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

17 related articles for article (PubMed ID: 8018849)

  • 1. Phytochemical analysis of
    Raafat K; Wurglics M
    J Tradit Complement Med; 2019 Oct; 9(4):263-270. PubMed ID: 31453121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo protection against strychnine toxicity in mice by the glycine receptor agonist ivermectin.
    Maher A; Radwan R; Breitinger HG
    Biomed Res Int; 2014; 2014():640790. PubMed ID: 25317421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic analysis and antiepileptic activity of N-valproyl derivatives of GABA and glycine.
    Hadad S; Bialer M
    Pharm Res; 1995 Jun; 12(6):905-10. PubMed ID: 7667199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-(benzyloxycarbonyl)glycine esters and amides as new anticonvulsants.
    Geurts M; Poupaert JH; Scriba GK; Lambert DM
    J Med Chem; 1998 Jan; 41(1):24-30. PubMed ID: 9438018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticonvulsant drug potentiation by glycine in maximal electroshock seizures is mimicked by D-serine and antagonized by 7-chlorokynurenic acid.
    Peterson SL
    Eur J Pharmacol; 1991 Jul; 199(3):341-8. PubMed ID: 1655484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation by glycine of anticonvulsant drugs in maximal electroshock seizures in rats.
    Peterson SL; Trzeciakowski JP; Frye GD; Adams HR
    Neuropharmacology; 1990 Apr; 29(4):399-409. PubMed ID: 2342638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro.
    Palmer GC; Harris EW; Ray R; Stagnitto ML; Schmiesing RJ
    Arch Int Pharmacodyn Ther; 1992; 317():16-34. PubMed ID: 1456842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic analysis and anticonvulsant activity of glycine and glycinamide derivatives.
    Sussan S; Dagan A; Bialer M
    Epilepsy Res; 1999 Jan; 33(1):11-21. PubMed ID: 10022362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant activities of N-benzyloxycarbonylglycine after parenteral administration.
    Lambert DM; Poupaert JH; Maloteaux JM; Dumont P
    Neuroreport; 1994 Mar; 5(7):777-80. PubMed ID: 8018849
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.